Search

Checkpoint: Roch Barbot & Gordon Bothe for Style Magazine Italia

CHECKPOINT: ROCH BARBOT & GORDON BOTHE FOR STYLE MAGAZINE ITALIA

Following a new campaign, we catch up with model Roch Barbot. The French model joins Gordon Bothe for an editorial. The models appear...

CRYSTAL STRUCTURE REVEALS HOW CURCUMIN IMPAIRS CANCER

Through x-ray crystallography and kinase-inhibitor specificity profiling, researchers reveal that curcumin, a natural occurring chemical...

 
 
 
Avengers: Infinity War To Get Possible Thanos Extended Cut

AVENGERS: INFINITY WAR TO GET POSSIBLE THANOS EXTENDED CUT

Avengers: Infinity War may get an extended cut on home video that will include more of Thanos' backstory. One of the biggest checkpoints...

 
 
 
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On

BIO ROUNDUP: BIG BUCKS FOR CALICO, DATA DUMPS & THE IPO WAVE ROLLS ON

If you're running a privately held biotech, the time to go public is now. Clinical data already in hand or not, biotechs have charged...

AstraZeneca's PARP Drug Is First to Help New Ovarian Cancer Patients

ASTRAZENECA'S PARP DRUG IS FIRST TO HELP NEW OVARIAN CANCER PATIENTS

Over the past few years, a new class of drugs known as “PARP” inhibitors have begun to change how ovarian cancer is treated. Data released...

 
 
 
New Way to Stop Drug-resistance in Prostate Cancer Identified

NEW WAY TO STOP DRUG-RESISTANCE IN PROSTATE CANCER IDENTIFIED

When one drug fails, a new door opens for the treatment of prostate cancer. The key resistance mechanism in prostate cancer and a molecular...

Lethal Prostate Cancer Treatment may Benefit from Combination Immunotherapy: Study

LETHAL PROSTATE CANCER TREATMENT MAY BENEFIT FROM COMBINATION IMMUNOTHERAPY: STUDY

A genetic subset of prostate cancer may benefit from the use of combination checkpoint immunotherapy.

 
 
 
Immune Profile for Successful Cancer Immunotherapy Identified

IMMUNE PROFILE FOR SUCCESSFUL CANCER IMMUNOTHERAPY IDENTIFIED

Multiple immune cell types must be present in tumors for 'checkpoint inhibitor' therapies to be effective.

New Drug Combination for High-Risk Neuroblastoma

NEW DRUG COMBINATION FOR HIGH-RISK NEUROBLASTOMA

Researchers create novel combination as potential therapy for high-risk neuroblastoma. This combination is made of epigenetic inhibitors...

 
 
 

MEDIVIR DELAYS PIVOTAL HDAC TRIAL AS FDA DISCUSSIONS STALL

A year ago, Medivir was riding high after reporting midstage data that encouraged it to press ahead with a pivotal trial of its HDAC...

New Treatment Target for Aggressive Liver Cancer in Kids

NEW TREATMENT TARGET FOR AGGRESSIVE LIVER CANCER IN KIDS

New therapeutic strategy can target aggressive form of pediatric liver cancer called hepatoblastoma which can provide a strong rationale...

 
 
 
Vince Vaughn arrested for DUI in California

VINCE VAUGHN ARRESTED FOR DUI IN CALIFORNIA

Vaughn was taken into custody at a routine checkpoint set up by local police.

Toy grenade causes bomb scare in Houston airport

TOY GRENADE CAUSES BOMB SCARE IN HOUSTON AIRPORT

HOUSTON - A toy grenade in a passenger's bag forced the shutdown of a security checkpoint at Houston's William P. Hobby Airport Thursday...

 
 
 

ASCO18: MIXED REACTION TO NEKTAR'S ‘CONFUSING' NKTR-214 TRIAL

Nektar Therapeutics' much-anticipated data from a study pairing its immuno-oncology prospect NKTR-214 with Bristol-Myers Squibb's checkpoint...

 
 
 
FDA Approves First of New Migraine Drugs

FDA APPROVES FIRST OF NEW MIGRAINE DRUGS

The FDA has approved the first in a new class of migraine drugs, called CGRP inhibitors, that aim to head off fight painful migraine...

 
 
 

TARGETING THE TRICKY PI3K PATHWAY IN CANCER, MEI GETS $75M TO PUSH PROGRAM THROUGH REGISTRATION STUDY

MEI Pharma $MEIP, a small public company in San Diego, has raised $75 million in a private sale of stock to push forward its PI3K inhibitor...

PUBLISHER CORRECTION: A SELECTIVE PEPTIDE INHIBITOR OF FRIZZLED 7 RECEPTORS DISRUPTS INTESTINAL STEM CELLS

Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells Publisher Correction: A...